This is a routine state administrative action expanding professional scope of practice for pharmacists in response to federal policy changes. A-score is minimal (0.76) - slight separation of powers consideration as state adapts to federal shift, but this is standard federalism functioning. Rule of law impact negligible as this follows normal regulatory authority. Single-state scope with moderate population yields 0.7 modifier. B-score (6.64) reflects modest media interest in COVID policy continuation but lacks significant outrage or strategic manipulation elements. No meaningful constitutional mechanism engaged - this is professional licensing adjustment, not rights restriction or institutional damage. Clear noise: routine health policy administration with no constitutional implications.